<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39512164</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1560-7917</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>45</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</Title><ISOAbbreviation>Euro Surveill</ISOAbbreviation></Journal><ArticleTitle>Detection of circulating type 3 vaccine-derived polioviruses in French Guiana, May to August 2024.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2400705</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2807/1560-7917.ES.2024.29.45.2400705</ELocationID><Abstract><AbstractText>Circulating type 3 vaccine-derived polioviruses (cVDPV3s) were detected in three wastewater samples collected in French Guiana from May through August 2024. As the oral polio vaccine is not used in French Guiana, this event involved an import either of cVDPV3s themselves or of a vaccine strain from which the cVDPV3s emerged in French Guiana. This highlights the importance of environmental surveillance for the detection of silent poliovirus circulation. Eliminating any pockets of cVDPVs is crucial for the polio eradication programme.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Raffestin</LastName><ForeName>Stéphanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Consortium OBEPINE, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut Pasteur de la Guyane, Laboratoire hygiène et environnement, Cayenne, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tinard</LastName><ForeName>Ambre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre collaborateur de l'OMS, Épidémiologie et macro-évolution des poliovirus and entérovirus non-polio, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Signalisation antivirale, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratoire associé au Centre national de référence entérovirus/paréchovirus, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Enfissi</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institut Pasteur de la Guyane, Laboratoire de virologie, Cayenne, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consortium OBEPINE, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joffret</LastName><ForeName>Marie-Line</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Centre collaborateur de l'OMS, Épidémiologie et macro-évolution des poliovirus and entérovirus non-polio, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratoire associé au Centre national de référence entérovirus/paréchovirus, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Signalisation antivirale, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lichtenstein</LastName><ForeName>Timothée</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institut Pasteur de la Guyane, Laboratoire de virologie, Cayenne, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tirera</LastName><ForeName>Sourakhata</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institut Pasteur de la Guyane, Laboratoire des interactions virus-hôtes, Cayenne, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zanetti</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Santé publique France, Direction des maladies infectieuses, Saint-Maurice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrau</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Santé publique France, Direction des régions, Cellules Guyane, Cayenne, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mubenga</LastName><ForeName>Francky</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Agence régionale de santé de Guyane, Direction de la santé publique Cayenne, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortelli</LastName><ForeName>Adrien</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Agence régionale de santé de Guyane, Direction de la santé publique Cayenne, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peyrefitte</LastName><ForeName>Christophe N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Institut Pasteur de la Guyane, Cayenne, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consortium OBEPINE, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lavergne</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institut Pasteur de la Guyane, Laboratoire des interactions virus-hôtes, Cayenne, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rousset</LastName><ForeName>Dominique</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institut Pasteur de la Guyane, Laboratoire de virologie, Cayenne, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consortium OBEPINE, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bessaud</LastName><ForeName>Maël</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institut Pasteur, Université Paris Cité, CNRS UMR 3569, Signalisation antivirale, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratoire associé au Centre national de référence entérovirus/paréchovirus, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre collaborateur de l'OMS, Épidémiologie et macro-évolution des poliovirus and entérovirus non-polio, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Sweden</Country><MedlineTA>Euro Surveill</MedlineTA><NlmUniqueID>100887452</NlmUniqueID><ISSNLinking>1025-496X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062065">Wastewater</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005616" MajorTopicYN="N" Type="Geographic">French Guiana</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="Y">Poliovirus Vaccine, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062065" MajorTopicYN="N">Wastewater</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004784" MajorTopicYN="N">Environmental Monitoring</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">environmental surveillance</Keyword><Keyword MajorTopicYN="N">oral polio vaccine</Keyword><Keyword MajorTopicYN="N">poliomyelitis</Keyword><Keyword MajorTopicYN="N">poliovirus</Keyword><Keyword MajorTopicYN="N">vaccine-derived poliovirus</Keyword></KeywordList><CoiStatement><b>Conflict of interest:</b> None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>14</Day><Hour>3</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>13</Day><Hour>13</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>8</Day><Hour>4</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39512164</ArticleId><ArticleId IdType="pmc">PMC11544717</ArticleId><ArticleId IdType="doi">10.2807/1560-7917.ES.2024.29.45.2400705</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Journal officiel de la République française. Décret n° 2018-42 du 25 janvier 2018 relatif à la vaccination obligatoire. [Decree on mandatory vaccination]. Paris: Journal officiel de la République française; 2018. French. Available from: https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000036543886
</Citation></Reference><Reference><Citation>Ministère des Affaires sociales et de l’Emploi. Bulletin épidémiologique hebdomadaire n°6/1987. [Weekly epidemiological bulletin]. Paris: Direction générale de la Santé; 1987. French. Available from: https://beh.santepubliquefrance.fr/beh/1987/06/beh_06_1987.pdf
</Citation></Reference><Reference><Citation>Haut Conseil de la santé publique. Conduite à tenir autour d’un cas de poliomyélite ou lors de la détection de poliovirus. Rapport du Haut Conseil de la santé publique. [Guidance for the response to a poliomyelitis case or a detection of poliovirus]. Paris: Haut Conseil de la santé publique. [Accessed: 24 Oct 2024]. French. Available from: https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=750
</Citation></Reference><Reference><Citation>Klapsa D, Wilton T, Zealand A, Bujaki E, Saxentoff E, Troman C, et al. Sustained detection of type 2 poliovirus in London sewage between February and July, 2022, by enhanced environmental surveillance. Lancet. 2022;400(10362):1531-8. 10.1016/S0140-6736(22)01804-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01804-9</ArticleId><ArticleId IdType="pmc">PMC9627700</ArticleId><ArticleId IdType="pubmed">36243024</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO). Guidelines for environmental surveillance of poliovirus circulation. Geneva: WHO; 2003. Available from: https://polioeradication.org/wp-content/uploads/2016/07/WHO_V-B_03.03_eng.pdf
</Citation></Reference><Reference><Citation>Thorley BR, Roberts JA. Isolation and Characterization of Poliovirus in Cell Culture Systems. Methods Mol Biol. 2016;1387:29-53. 10.1007/978-1-4939-3292-4_4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-3292-4_4</ArticleId><ArticleId IdType="pubmed">26983730</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerloff N, Sun H, Mandelbaum M, Maher C, Nix WA, Zaidi S, et al. Diagnostic assay development for poliovirus eradication. J Clin Microbiol. 2018;56(2):e01624-17. 10.1128/JCM.01624-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01624-17</ArticleId><ArticleId IdType="pmc">PMC5786708</ArticleId><ArticleId IdType="pubmed">29212703</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns CC, Kilpatrick DR, Iber JC, Chen Q, Kew OM. Molecular properties of poliovirus isolates: nucleotide sequence analysis, typing by PCR and real-time RT-PCR. Methods Mol Biol. 2016;1387:177-212. 10.1007/978-1-4939-3292-4_9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-3292-4_9</ArticleId><ArticleId IdType="pubmed">26983735</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Polio Eradication Initiative. Classification and reporting of vaccine-derived polioviruses (VDPV). Geneva: Global Polio Eradication Initiative; 2016. Available from: https://polioeradication.org/wp-content/uploads/2016/09/Reporting-and-Classification-of-VDPVs_Aug2016_EN.pdf
</Citation></Reference><Reference><Citation>Combelas N, Holmblat B, Joffret ML, Colbère-Garapin F, Delpeyroux F. Recombination between poliovirus and coxsackie A viruses of species C: a model of viral genetic plasticity and emergence. Viruses. 2011;3(8):1460-84. 10.3390/v3081460</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v3081460</ArticleId><ArticleId IdType="pmc">PMC3185806</ArticleId><ArticleId IdType="pubmed">21994791</ArticleId></ArticleIdList></Reference><Reference><Citation>Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol. 2005;59(1):587-635. 10.1146/annurev.micro.58.030603.123625</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.micro.58.030603.123625</ArticleId><ArticleId IdType="pubmed">16153180</ArticleId></ArticleIdList></Reference><Reference><Citation>Agence régionale de santé Guyane. ARS newsletter. Cayenne: Agence régionale de santé Guyane; 2024. Available from: https://eye.newsletter.ars.sante.fr/m2?r=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
</Citation></Reference><Reference><Citation>Geiger K, Stehling-Ariza T, Bigouette JP, Bennett SD, Burns CC, Quddus A, et al. Progress toward poliomyelitis eradication - worldwide, January 2022-December 2023. MMWR Morb Mortal Wkly Rep. 2024;73(19):441-6. 10.15585/mmwr.mm7319a4</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7319a4</ArticleId><ArticleId IdType="pmc">PMC11115430</ArticleId><ArticleId IdType="pubmed">38753550</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns CC, Diop OM, Sutter RW, Kew OM. Vaccine-derived polioviruses. J Infect Dis. 2014;210(Suppl 1):S283-93. 10.1093/infdis/jiu295</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu295</ArticleId><ArticleId IdType="pubmed">25316847</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohanty A, Rohilla R, Zaman K, Hada V, Dhakal S, Shah A, et al. Vaccine derived poliovirus (VDPV). Infez Med. 2023;31(2):174-85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10241397</ArticleId><ArticleId IdType="pubmed">37283637</ArticleId></ArticleIdList></Reference><Reference><Citation>Raharinantoanina J, Joffret ML, Bessaud M, Rakoto DAD, Dussart P, Lacoste V, et al. Wide circulation of type 1 vaccine-derived poliovirus strains in clinical specimens from suspected cases of poliomyelitis, their contacts and in wastewater in Madagascar since late 2020. Virology. 2024;600:110253. 10.1016/j.virol.2024.110253</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2024.110253</ArticleId><ArticleId IdType="pubmed">39357254</ArticleId></ArticleIdList></Reference><Reference><Citation>Oduoye MO, Ubechu SC, Mourid MR, Ahmad AI, Adegoke AA, Arama UO, et al. Re-emergence of vaccine-derived polio in the demographic Republic of Congo: Causes and consequences. New Microbes New Infect. 2024;62:101489. 10.1016/j.nmni.2024.101489</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmni.2024.101489</ArticleId><ArticleId IdType="pmc">PMC11460244</ArticleId><ArticleId IdType="pubmed">39381618</ArticleId></ArticleIdList></Reference><Reference><Citation>Weil M, Sofer D, Shulman LM, Weiss L, Levi N, Aguvaev I, et al. Environmental surveillance detected type 3 vaccine-derived polioviruses in increasing frequency at multiple sites prior to detection of a poliomyelitis case. Sci Total Environ. 2023;871:161985. 10.1016/j.scitotenv.2023.161985</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scitotenv.2023.161985</ArticleId><ArticleId IdType="pubmed">36739034</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorba J, Campagnoli R, De L, Kew O. Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range. J Virol. 2008;82(9):4429-40. 10.1128/JVI.02354-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02354-07</ArticleId><ArticleId IdType="pmc">PMC2293050</ArticleId><ArticleId IdType="pubmed">18287242</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacher M, Epelboin L, Bonifay T, Djossou F, Blaizot R, Couppié P, et al. Migration in French Guiana: Implications in health and infectious diseases. Travel Med Infect Dis. 2024;57:102677. 10.1016/j.tmaid.2023.102677</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2023.102677</ArticleId><ArticleId IdType="pubmed">38049022</ArticleId></ArticleIdList></Reference><Reference><Citation>Breton D, Marie CV, Floury E, Crouzet M, Lottin A, Taupe G, et al. Migrations, Famille et Vieillissement en Guyane. Institut national d’études démographiques. [Migration, family and ageing in French Guina]. Aubervilliers: Institut national d’études démographiques; 2023. French. Available from: https://www.ined.fr/fichier/s_rubrique/34297/brochure_mfv_guyane_04.12.fr.pdf
</Citation></Reference><Reference><Citation>Kasstan B, Mounier-Jack S, Chantler T, Masters N, Flores SA, Stokley S, et al. Poliovirus outbreak in New York State, August 2022: qualitative assessment of immediate public health responses and priorities for improving vaccine coverage. Epidemiol Infect. 2023;151:e120. 10.1017/S0950268823001127</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268823001127</ArticleId><ArticleId IdType="pmc">PMC10468811</ArticleId><ArticleId IdType="pubmed">37435800</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuckerman NS, Bar-Or I, Sofer D, Bucris E, Morad H, Shulman LM, et al. Emergence of genetically linked vaccine-originated poliovirus type 2 in the absence of oral polio vaccine, Jerusalem, April to July 2022. Euro Surveill. 2022;27(37):2200694. 10.2807/1560-7917.ES.2022.27.37.2200694</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2022.27.37.2200694</ArticleId><ArticleId IdType="pmc">PMC9479469</ArticleId><ArticleId IdType="pubmed">36111556</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandyopadhyay AS, Lopez Cavestany R, Blake IM, Macklin G, Cooper L, Grassly N, et al. Use of inactivated poliovirus vaccine for poliovirus outbreak response. Lancet Infect Dis. 2024;24(5):e328-42. 10.1016/S1473-3099(23)00505-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00505-4</ArticleId><ArticleId IdType="pubmed">38012892</ArticleId></ArticleIdList></Reference><Reference><Citation>Shulman LM, Martin J, Sofer D, Burns CC, Manor Y, Hindiyeh M, et al. Genetic analysis and characterization of wild poliovirus type 1 during sustained transmission in a population with &gt;95% vaccine coverage, Israel 2013. Clin Infect Dis. 2015;60(7):1057-64. 10.1093/cid/ciu1136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciu1136</ArticleId><ArticleId IdType="pubmed">25550350</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishore N, Krow-Lucal E, Diop OM, Jorba J, Avagnan T, Grabovac V, et al. Surveillance to track progress toward polio eradication - worldwide, 2022-2023. MMWR Morb Mortal Wkly Rep. 2024;73(13):278-85. 10.15585/mmwr.mm7313a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7313a1</ArticleId><ArticleId IdType="pmc">PMC10997045</ArticleId><ArticleId IdType="pubmed">38573841</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol. 2018;35(6):1547-9. 10.1093/molbev/msy096</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msy096</ArticleId><ArticleId IdType="pmc">PMC5967553</ArticleId><ArticleId IdType="pubmed">29722887</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>